Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 17, 2025 • 2:51 PM ET

Date/Time Source News Release
05/14/2025 08:05 AM EDT ACCESS Newswire Xenetic Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
04/09/2025 09:15 AM EDT ACCESS Newswire Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
03/26/2025 09:00 AM EDT ACCESS Newswire Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Relapsed/Refractory Osteosarcoma and Ewing Sarcoma
03/19/2025 08:05 AM EDT ACCESS Newswire Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results
03/13/2025 08:30 AM EDT ACCESS Newswire Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses
02/27/2025 09:15 AM EST ACCESS Newswire Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting
12/17/2024 09:15 AM EST ACCESSWIRE Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
12/16/2024 09:00 AM EST ACCESSWIRE Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform
12/05/2024 08:45 AM EST ACCESSWIRE Xenetic Biosciences, Inc. Enters into Clinical Trial Services Agreement with PeriNess Ltd. to Accelerate Development of DNase I Oncology Program
11/22/2024 09:15 AM EST ACCESSWIRE Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Page

Additional News

As of June 17, 2025 • 2:51 PM ET

Date/Time Source News Release
05/14/2025 08:21 AM EDT SeekingAlpha Xenetic Biosciences reports Q1 results
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Xenetic Biosciences Inc.
04/22/2025 05:15 PM EDT Zacks USANA Health Sciences (USNA) Q1 Earnings and Revenues Surpass Estimates
03/19/2025 08:11 AM EDT SeekingAlpha Xenetic Biosciences reports FY results
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Xenetic Biosciences Inc.
11/13/2024 03:46 PM EST SeekingAlpha Xenetic Biosciences GAAP EPS of -$0.28, revenue of $614.1M
11/12/2024 05:35 PM EST Zacks Progyny (PGNY) Tops Q3 Earnings Estimates
11/07/2024 05:15 PM EST Zacks Rigel Pharmaceuticals (RIGL) Q3 Earnings and Revenues Top Estimates
10/21/2024 05:14 PM EDT SeekingAlpha Xenetic Biosciences files for $50M mixed securities shelf
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.